Page 1

Point-of-Care Testing (POCT) Market Share will Increase US$ 35 Billion By 2022

Market Research Engine has published a new report titled as “Point-of-Care Testing (POCT) Market By Product Type (Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing); By End-User Type (Clinics, Home, Laboratories, Assisted living healthcare facilities, Hospitals) and by regional analysis - global forecast by 2016 - 2022”. POCT is considered together of the foremost reasonable technologies of world medical specialty market, and development in POCT technologies over amount of your time has been meted out through innovations in smart and transportable bio-sensor, computing, and knowledge and communication technologies. According to market consultants the factors helping the expansion of POC medical specialty market are many government initiatives have power-assisted within the development of innovative outpatient care models, to reduce hospital stays and quickly increasing demand for home health care globally. The Global Point-of-Care Testing (POCT) Market is expected to exceed more than US$ 35.2 Billion by 2022 at a CAGR of 9% in the given forecast period. You Can Browse Full Report: https://www.marketresearchengine.com/point-of-care-testing-market The major driving factors of Global Point-of-Care Testing (POCT) Market are as follows:       

High Prevalence of Infectious Diseases in Developing Countries Increasing Incidence of life style Diseases personal Investments and risk capital Activities Technological Advancements and New Product Launches Growing range of restrictive Approvals for Novel immunochemical assay Techniques Shortage of complete Laboratory Technicians Increasing Preference of POC Testing Rising range of Clia-Waived POC Tests

The restraining factors of Global Point-of-Care Testing (POCT) Market are as follows:


  

Product recollects Pricing Pressures as a result of compensation Cuts and Budget Constraints Hampering Profits Demanding and time-consuming restrictive Policies

The Global Point-of-Care Testing (POCT) Market is segmented on the lines of its technology, treatment, application and regional. Based on product type segmentation it covers Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing and Others. Based on End user it covers Clinics, Home, Laboratories, Assisted living healthcare facilities and Hospitals. Global Point-of-Care Testing (POCT) Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries. This report provides: 1)An overview of the global market for Global Point-of-Care Testing (POCT) Market and related technologies. 2)Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022. 3)Identifications of new market opportunities and targeted promotional plans for Global Point-of-Care Testing (POCT) Market. 4)Discussion of research and development, and the demand for new products and new applications. 5)Comprehensive company profiles of major players in the industry. Report Scope: The scope of the report includes a detailed study of Global Point-of-Care Testing (POCT) Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Acrongenomics, Inc., Siemens AG, Abbott Laboratories, Inc. Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, OPTI Medical, Sienco, Inc. AccuBioTech Co., Ltd., ACON Laboratories, Inc., bioMérieux SA, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc. Alpha Scientific, Bio-Rad


Laboratories, Inc., Medica Corporation, and Nova Biomedical among others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. The Global Point-of-Care Testing (POCT) Market has been segmented as below: By Product Type:         

Glucose Monitoring Cardiac Markers Infectious Diseases Testing Cholesterol Testing Coagulation Monitoring Pregnancy And Fertility Testing Hematology Testing Blood Gas Testing Others

By End-User Type:     

Clinics Home Laboratories Assisted living healthcare facilities Hospitals

By Regional Analysis:    

North America Europe Asia-Pacific Rest of the World

You Can Browse Full Report: https://www.marketresearchengine.com/point-of-care-testing-market

Table of Contents 1 INTRODUCTION 2 Research Methodology


3Executive Summary 4Premium Insights 5Market Overview 6Cardiac Monitoring Market, By Product 7Point-Of-Care Diagnostics Market, By Product 8Point-Of-Care Diagnostics Market, By Prescription Mode 9 Point-Of-Care Diagnostics Market, By End User 10 Point-Of-Care Diagnostics Market, By Region 11 Competitive Landscape 12 Company Profiles 1.

Introduction

2.

Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)

3.

Abbott Laboratories, Inc.

4.

Siemens AG

5.

Alere Inc.

6.

Johnson & Johnson

7.

Instrumentation Laboratory (A Werfen Company)

8.

Nova Biomedical

9.

Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)

10.

Becton, Dickinson and Company

Media 11. Contact PTs Diagnostics Company Name: Market Research Engine Contact Person: John Bay


Email: john@marketresearchengine.com Phone: +1-855-984-1862 Country: United States Website: https://www.marketresearchengine.com/

Point-of-Care Testing (POCT) Market Share will Increase US$ 35 Billion By 2022  
Point-of-Care Testing (POCT) Market Share will Increase US$ 35 Billion By 2022  

The Global Point-of-Care Testing (POCT) Market is expected to exceed more than US$ 35.2 Billion by 2022 at a CAGR of 9% in the given forecas...

Advertisement